Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice

Journal of Autoimmunity

Volumn 12, Issue 4, 1999, Pages 243-249

  Kimura, Toshihisa ^a   Ito, Akihiko ^a   Hancock, Wayne W ^b   Maki, Takashi ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Diabetogenic process; Islet mass; Islet transplantation; Pancreatectomy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; IMMUNE RESPONSE; IMMUNOREACTIVITY; ISOGRAFT; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PRIORITY JOURNAL; XENOGRAFT;

EID: 0033019489     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0283     Document Type: Article

References (24)

1. Serreze D.V., Leiter E.H. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6:1994;900-906.
2. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mice. Annu. Rev. Immunol. 13:1995;179-200.
3. Gazda L.S., Chalton H., Lafferty K.J. Diabetes results from a late change in the autoimmune response of NOD mice. J. Autoimmun. 10:1997;261-270.
4. Ogawa M., Maruyama T., Haregawa T., Kanaya T., Kobayashi F., Tochino Y., Uda H. The inhibitory effect of neonatal thymectomy on the incidence of insulitis on non-obese diabetic (NOD) mice. Biomed. Res. 6:1985;103-108.
5. Wicker L.S., Miller B.J., Mullen Y. Transfer of autoimmune diabetes mellitus with SPC from nonobese diabetic (NOD) mice. Diabetes. 35:1986;855-859.
6. Wang Y., Hao L., Gill R.G., Lafferty K.J. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes. 36:1987;535-538.
7. +cells. J. Exp. Med. 166:1988;823-832.
8. Shizuru J.A., Taylor-Edwards C., Banks B.A., Gregory A.L., Fathman C.G. Immunotherapy of the nonobese diabetic mouse treatment with an antibody to T-helper lymphocytes. Science. 240:1988;659-662.
9. +T-cells from diabetic versus prediabetic NOD.NON-thy-Ia donors. Diabetes. 42:1993;44-55.
10. Larger E., Becourt C., Bach J.F., Boitard C. Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. J. Exp. Med. 181:1995;1635-1642.
11. Itoh A., Maki T. Protection of NOD mice from autoimmune diabetes by reduction of islet mass prior to insulitis. Proc. Natl. Acad. Sci. USA. 93:1996;11053-11056.
12. Maki T., Ichikawa T., Blanco R., Porter J. Long-term abrogation of autoimmunity in spontaneously diabetic NOD mice by immunotherapy with anti-lymphocyte serum. Proc. Natl. Acad. Sci. USA. 89:1992;3434-3438.
13. Gotoh M., Maki T., Kiyoizumi T., Satomi S., Monaco A.P. An improved method for isolation of mouse pancreatic islets. Transplantation. 40:1985;437-438.
14. Hancock W.W., Syegh M.H., Zheng X.G., Peach R., Linsley P.S., Turka L.A. Costimulatory function and expression of CD40 ligand, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA. 93:1996;13967-13972.
15. Harada M., Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia. 27:1984;604-606.
16. Oldstone M.B. Overview: infectious agents as etiologic triggers of autoimmune disease. Curr. Top. Microbiol. Immunol. 145:1989;1-3.
17. Yoon J.W. The role of viruses and environmental factors in the induction of diabetes. Curr. Top. Microbiol. Immunol. 164:1990;95-123.
18. Bonner-Weir S., Trent D.F., Weir G.C. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J. Clin. Invest. 71:1983;1544-1553.
19. Brockenbrough J.S., Weir G.C., Bonner-Weir S. Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes. 37:1988;232-236.
20. Gonzalez A., Katz J.D., Mattei M.G., Kikutani H., Benoist C., Mathis D. Genetic control of diabetes progression. Immunity. 7:1997;873-883.
21. Shimada A., Charlton B., Taylor-Edwards C., Fathman C.G. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes. 45:1996;1063-1067.
22. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes. 43:1994;613-621.
23. Andre I., Gonzalez A., Wang B., Katz J., Benoist C., Mathis D. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models. Proc. Natl. Acad. Sci. USA. 93:1996;2260-2263.
24. Gorsuch A.N., Lister J., Dean B.M., Spencer K.M., McNally J.M., Bottazo G.F. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet. 2:1981;1363-1365.